UNSPSC 51152044: Silperisone

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R16SK8726X. European Medicines Agency schedules Silperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10521MIG. Silperisone generally arises in the molecular formula C15H24FNSI.

UNSPSC 51152044 Silperisone is a Commodity code that in recent state and local procurement activity has been applied to pharmaceutical products and drug-management systems rather than silperisone specifically. Seminole County, Florida and the Texas Health and Human Services Commission have posted opportunities tagged to this code that address naloxone procurement, safe drug deactivation systems, and direct-to-manufacturer prescription fulfillment — all substantially outside the nominal scope of a single active pharmaceutical ingredient. State and local issuing bodies using this code span county health departments and state health and human services agencies. The geographic footprint in recent activity includes Florida and Texas.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford; the contract term is two years with an optional one-year renewal and includes FEMA funding compliance requirements. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program enabling direct contracting between state agencies and pharmaceutical manufacturers outside traditional pharmacy benefit manager channels; the RFI closed April 3, 2026, and is exploratory in nature, designed to inform future formal procurement strategy rather than to award a contract immediately. The mismatch between the code's pharmaceutical ingredient name and the actual scope of solicitations suggests this code has limited direct relevance to state and local procurement activity or has been misapplied in recent tagging.